Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

Re-adapting T cells for cancer therapy: from mouse models to clinical trials.
复制标题

DOI:
10.1111/imr.12141
复制
发表时间:
2014-01
影响因子:
8.7
通讯作者:
Greenberg PD
Greenberg PD
中科院分区:
医学1区
文献类型:
--
作者:
Stromnes IM;Schmitt TM;Chapuis AG;Hingorani SR;Greenberg PD

文献摘要

参考文献

被引文献

相似文献

过继性T细胞治疗包括分离、扩增和再输注具有明确特异性和功能的T淋巴细胞,作为根除癌症的一种手段。我们的研究重点是在小鼠模型中通过抗原特异性T细胞和T细胞转导表达特定的T细胞受体(TCR)来明确肿瘤根除的要求,然后将这些策略转化为临床试验。我们的基于t细胞的癌症治疗设计反映了我们在确定限制小鼠和人类持续效应t细胞活性的障碍,设计增强t细胞持久性的方法,开发增加TCR亲和力/ t细胞功能贪婪的方法,以及寻求克服耐受性和免疫抑制的策略方面的努力。随着基因工程的出现,高功能的T细胞群现在可以快速生成并针对目标恶性肿瘤进行定制。在忠实和信息丰富的小鼠模型中进行的临床前研究,以及从临床试验的成功和局限性分析中获得的知识,正在塑造我们如何继续发展、完善和扩大这种方法在癌症治疗中的适用性。
Adoptive T-cell therapy involves the isolation, expansion and reinfusion of T lymphocytes with a defined specificity and function as a means to eradicate cancer. Our research has focused on specifying the requirements for tumor eradication with antigen-specific T cells and T cells transduced to express a defined T-cell receptor (TCR) in mouse models and then translating these strategies to clinical trials. Our design of T-cell-based therapy for cancer has reflected efforts to identify the obstacles that limit sustained effector T-cell activity in mice and humans, design approaches to enhance T-cell persistence, develop methods to increase TCR affinity/T-cell functional avidity, and pursue strategies to overcome tolerance and immunosuppression. With the advent of genetic engineering, a highly functional population of T cells can now be rapidly generated and tailored for the targeted malignancy. Preclinical studies in faithful and informative mouse models, in concert with knowledge gained from analyses of successes and limitations in clinical trials, are shaping how we continue to develop, refine, and broaden the applicability of this approach for cancer therapy.
DOI: 10.1172/jci32103
发表时间: 2008-01-01
影响因子: 15.9
作者:
Berger, Carolina;Jensen, Michael C.;Riddell, Stanley R.
通讯作者: Riddell, Stanley R.
DOI: 10.1182/blood-2009-12-260539
发表时间: 2010-06-10
期刊: BLOOD
影响因子: 20.3
作者:
Bleakley, Marie;Otterud, Brith E.;Riddell, Stanley R.
通讯作者: Riddell, Stanley R.
DOI: 10.4049/jimmunol.175.2.755
发表时间: 2005-07-15
影响因子: 4.4
作者:
Alves, NL;Arosa, FA;van Lier, RAW
通讯作者: van Lier, RAW
DOI: 10.1016/s1074-7613(00)80260-5
发表时间: 1996-10-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Bruno, L;Fehling, HJ;vonBoehmer, H
通讯作者: vonBoehmer, H
DOI: 10.1111/j.1600-0609.2008.01158.x
发表时间: 2009-01-01
影响因子: 3.1
作者:
Candoni, Anna;Tiribelli, Mario;Fanin, Renato
通讯作者: Fanin, Renato